1. Home
  2. PDSB vs KORE Comparison

PDSB vs KORE Comparison

Compare PDSB & KORE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDSB
  • KORE
  • Stock Information
  • Founded
  • PDSB 2005
  • KORE 2003
  • Country
  • PDSB United States
  • KORE United States
  • Employees
  • PDSB N/A
  • KORE N/A
  • Industry
  • PDSB Biotechnology: Pharmaceutical Preparations
  • KORE Telecommunications Equipment
  • Sector
  • PDSB Health Care
  • KORE Consumer Discretionary
  • Exchange
  • PDSB Nasdaq
  • KORE Nasdaq
  • Market Cap
  • PDSB 43.1M
  • KORE 42.5M
  • IPO Year
  • PDSB N/A
  • KORE N/A
  • Fundamental
  • Price
  • PDSB $1.28
  • KORE $2.56
  • Analyst Decision
  • PDSB Strong Buy
  • KORE Hold
  • Analyst Count
  • PDSB 3
  • KORE 1
  • Target Price
  • PDSB $10.00
  • KORE $2.50
  • AVG Volume (30 Days)
  • PDSB 279.1K
  • KORE 14.8K
  • Earning Date
  • PDSB 05-14-2025
  • KORE 05-14-2025
  • Dividend Yield
  • PDSB N/A
  • KORE N/A
  • EPS Growth
  • PDSB N/A
  • KORE N/A
  • EPS
  • PDSB N/A
  • KORE N/A
  • Revenue
  • PDSB N/A
  • KORE $285,229,000.00
  • Revenue This Year
  • PDSB N/A
  • KORE $3.89
  • Revenue Next Year
  • PDSB N/A
  • KORE $5.35
  • P/E Ratio
  • PDSB N/A
  • KORE N/A
  • Revenue Growth
  • PDSB N/A
  • KORE 7.01
  • 52 Week Low
  • PDSB $0.85
  • KORE $1.10
  • 52 Week High
  • PDSB $4.42
  • KORE $4.88
  • Technical
  • Relative Strength Index (RSI)
  • PDSB 59.26
  • KORE 54.74
  • Support Level
  • PDSB $1.00
  • KORE $2.25
  • Resistance Level
  • PDSB $1.17
  • KORE $2.66
  • Average True Range (ATR)
  • PDSB 0.10
  • KORE 0.17
  • MACD
  • PDSB 0.04
  • KORE 0.02
  • Stochastic Oscillator
  • PDSB 91.84
  • KORE 82.16

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

About KORE KORE Group Holdings Inc.

Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates a majority of its revenue from the United States and the rest from other countries.

Share on Social Networks: